![4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid (CAS 18623-44-4) - chemical structure image](https://media.scbt.com/product/4-5-3-4-dimethoxy-benzylidene-4-oxo-2-thioxo-thiazolidin-3-yl-butyric-acid-18623-44-4-structure_20_06_b_200624.jpg)
![4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid (CAS 18623-44-4) - chemical structure image](https://media.scbt.com/product/4-5-3-4-dimethoxy-benzylidene-4-oxo-2-thioxo-thiazolidin-3-yl-butyric-acid-18623-44-4-structure_20_06_t_200624.jpg "Molecular structure of 4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid, CAS Number: 18623-44-4")
Molecular structure of 4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid, CAS Number: 18623-44-4
4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid (CAS 18623-44-4)
Alternate Names:
iCRT5
CAS Number:
18623-44-4
Molecular Weight:
367.440
Molecular Formula:
C16H17NO5S2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
The compound known as 4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid is a blocker of the insulin receptor signaling pathway. Extensive in vitro studies have demonstrated its ability to impede the growth of cancer cells, all the while leaving normal cells unaffected. The primary mode of action is believed to involve the suppression of β-catenin. This leads to the inhibition of soluble guanylate cyclase and the natural compounds that regulate cellular signaling pathways.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
4-[5-(3,4-Dimethoxy-benzylidene)-4-oxo-2-thioxo-thiazolidin-3-yl]-butyric acid, 10 mg | sc-276969 | 10 mg | $128.00 |